1. What is LASA Medication?
Medication safety is a key responsibility for all medical professionals. Each day, millions of medications are prescribed, given out, and used around the world. Most treatments are safe, but medication errors still happen and cause preventable harm. Confusing Look-Alike and Sound-Alike (LASA) medications is one of the greatest continuing difficulties.
LASA medications are drugs with names, packaging, labels, or appearances that are so similar they can be mixed up. These similarities can cause healthcare workers to pick, give out, or use the wrong medicine. Mistakes like this can happen in hospitals, pharmacies, clinics, nursing homes, or even at home. Some LASA errors are minor, but others may lead to serious injury, permanent disability, or death.
The World Health Organization (WHO) sees medication errors as a major global patient safety problem. To address this, WHO started the Global Patient Safety Challenge: Medication Without Harm. This program intends to lower serious and preventable harm by improving how medications are used worldwide. LASA medications are a main focus because many of these mistakes can be predicted and stopped.
A tragic example happened when a newborn was given epinephrine instead of vitamin K because the vials looked alike. This mistake led to the infant’s death and showed how several system failures can combine to cause a disaster. Today, this case is used as an important lesson in patient safety programs around the world.
This article examines the global impact of medication errors, explains what LASA medications are, reviews a real-life case of a fatal mix-up, discusses the main causes, and shares practical steps that pharmacists and healthcare organizations can use to help prevent these mistakes.
2. Global Burden of Medication Errors
Medication errors occur in every country, regardless of the healthcare system or available resources. International patient safety organizations report that harm from medication mistakes is one of the main causes of preventable injury in healthcare.
Medication mistakes can occur at any stage of the medication process:
• Prescribing
• Transcribing
• Dispensing
• Preparing
• Administering
• Monitoring
Mistakes can happen at any stage and may reach patients if there are not enough safety checks.
Multiple factors contribute to medication errors, including:
• Increasing complexity of healthcare
• Heavy workloads
• Communication failures
• Similar drug names and packaging
• Human limitations such as fatigue and distraction
Medication errors can have serious effects. Patients might have bad reactions to drugs, stay in the hospital longer, face treatment delays, or even suffer permanent harm or death. These mistakes also raise healthcare costs due to extra treatments, lawsuits, and efforts to improve quality.
Children, newborns, and very sick patients are especially at risk because even small mistakes in picking or dosing medicine can have serious results.
3. Understanding LASA Medications
Look-Alike and Sound-Alike medications are drugs that can be confused because their names, packaging, labels, or appearance are similar.
Confusion with these medicines can occur when they are prescribed, dispensed, prepared, or administered to patients.
Common forms of similarity include:
A. Similar Drug Names
• Dopamine and Dobutamine
• Hydralazine and Hydroxyzine
• Prednisone and Prednisolone
• Clonidine and Klonopin
B. Similar Packaging
• Same vial size
• Similar label colors
• Similar font styles
• Comparable package design
C. Similar Labeling
Labels with small font sizes, poor contrast, or crowded layouts can make it hard to tell important information apart.
D. Similar Physical Appearance
Tablets, capsules, ampoules, and vials for injections can sometimes look very similar.
Why LASA Errors Occur ?
• Time pressure
• Interruptions
• Fatigue
• Poor storage practices
• Inadequate authentication procedures
Since LASA errors frequently involve risks we can predict, healthcare organizations have a real chance to prevent them by improving their systems.
4. Real Case Study: The Tragic Death of Infant Zoya Due to Medication Mix-Up
One of the most widely discussed medication-safety cases involved a newborn infant named Zoya.
Shortly after birth, Zoya required routine administration of vitamin K. Vitamin K injections are commonly given to newborns to prevent Vitamin K Deficiency Bleeding (VKDB). This potentially serious condition can result in spontaneous bleeding and life-threatening complications.
In the healthcare facility where the incident occurred, vitamin K and epinephrine were stored in similar containers. The vials shared several visual characteristics, including matching size and labeling features. During medication selection, a medical practitioner inadvertently chose epinephrine instead of vitamin K. The medication was subsequently administered to the infant.
Shortly after administration, the newborn developed severe physiological complications consistent with exposure to epinephrine. Healthcare providers initiated emergency treatment efforts, but despite intervention, the infant died. The event was devastating for the family and deeply affected the healthcare professionals involved. A later investigation found that this tragedy was not caused by just one careless mistake, but by several system failures that let the error go unnoticed. Patient safety organizations worldwide now use this case to show the dangers of LASA medications.
5. Timeline of Events
A. Birth and Initial Care
The infant was delivered successfully and entered routine postnatal care. Healthcare professionals prepared to administer standard newborn medications.
B. Vitamin K Requirement Identified
According to established neonatal protocols, vitamin K administration was required shortly after birth.
C. Medication Selection
A healthcare worker retrieved what was believed to be a vitamin K vial. However, because epinephrine and vitamin K appeared similar, the incorrect medication was selected.
D. Medication Preparation
The medication was prepared for administration. At this stage, an opportunity existed to detect the error using careful label verification or an independent double-check process.
E. Administration
The medication was administered to the infant. The wrong drug reached the patient because multiple safety barriers had failed.
F. Clinical Deterioration
Soon after administration, the infant began experiencing adverse physiological effects. Healthcare providers recognized that the newborn's condition was worsening.
G. Emergency Response
Medical personnel initiated emergency treatment and resuscitation efforts.
H. Fatal Outcome
The infant died as a result of complications associated with the medication error.
6. Root Cause Analysis
Root Cause Analysis (RCA) is a formal approach used to identify fundamental causes that contribute to adverse events. Rather than focusing solely on personal actions, RCA examines system weaknesses that create conditions for errors to occur.
The investigation found several important contributing factors.
A. Similar Packaging and Appearance
One of the major contributors was the visual similarity between the vitamin K and epinephrine vials. Healthcare workers frequently rely on visual cues during medication selection. When products appear nearly identical, confusion becomes more likely.
B. Storage-Related Risks
The medications were stored in a manner that allowed accidental selection. When LASA medications are located close together, the probability of choosing the wrong product increases substantially.
C. Lack of Effective Verification
Multiple opportunities existed to detect the error before administration. However, no robust verification process successfully intercepted the mistake.
D. Human Factors
Human mental limitations also played a role in the incident. Factors may have included:
• Time pressure
• Distraction
• Fatigue
• Reliance on visual recognition
• Expectation bias
Healthcare professionals often identify medications by how they look instead of reading every label carefully. This is understandable in busy clinical settings, but it can be dangerous when LASA medications are involved.1–6)
7. Human Factors and System Failures
Human factors engineering examines how people interact with systems, equipment, technology, and work environments. Modern patient-safety research recognizes that errors rarely occur because healthcare professionals lack competence. Instead, mistakes often arise when system design does not account for predictable human limitations.
A. Attention Limitations
Healthcare professionals process large amounts of information throughout their shifts. They must monitor patients, review medications, communicate with colleagues, and respond to emergencies. Under such conditions, attention may become divided, increasing the risk of ignoring critical details on medication labels.
B. Fatigue
Fatigue is a well-documented contributor to medication errors. Long working hours, night shifts, inadequate rest, and staffing shortages may impair concentration, memory, and decision-making abilities.
C. Interruptions and Distractions
Medication preparation and administration tasks are frequently interrupted by phone calls, alarms, patient requests, and conversations with coworkers. Studies have consistently shown that interruptions increase the likelihood of medication-selection errors.
D. Time Pressure
Healthcare professionals often work under strict time constraints. During emergencies, staff may rely on visual recognition rather than carefully verifying medication labels.
E. Confirmation Bias
Confirmation bias occurs when individuals see what they expect to see rather than what is actually present. A healthcare worker expecting to retrieve vitamin K could unconsciously interpret a similar-looking vial as the correct medication.
F. System Design Failures
Poorly designed systems create opportunities for errors. Examples include:
• Similar packaging
• Poor storage practices
• Lack of barcode scanning
• Inadequate staffing
• Ineffective double-check procedures
Modern patient safety principles stress that medical systems should be designed to expect human error and prevent mistakes from reaching patients.
8. Clinical Consequences of LASA errors
The consequences of LASA medication errors may differ considerably based on the medications involved, the patient's condition, and the timing of error detection.
A. Mild Harm
Some LASA errors result in temporary discomfort or minor adverse effects. Patients may require observation or minor treatment modifications but recover without lasting consequences.
Examples include:
• Mild allergic reactions
• Temporary symptoms
• Delayed treatment
B. Moderate Harm
Moderate harm may require additional medical intervention and prolonged hospitalization.
Examples include:
• Significant adverse drug reactions
• Need for additional medications
• Reversible organ dysfunction
• Extended hospital stays
C. Severe Harm
Certain LASA errors can result in permanent injury.
Examples include:
• Neurological damage
• Organ failure
• Permanent disability
• Serious cardiovascular complications
D. Death
The most serious medication errors can be fatal. Administration of a potent medication to the wrong patient or administration of the wrong drug to a vulnerable patient may result in death.
Newborns are particularly vulnerable because:
• Their body weight is low
• Organ systems are immature
• Drug metabolism differs from adults
• Small dosing errors can have major effects
The death of infant Zoya demonstrates the potentially disastrous effects of LASA medication errors.
9. Common LASA Drug Pairs in Pharmacy Practice
Pharmacists and healthcare professionals should remain familiar with commonly confused medication pairs.
A. Dopamine vs Dobutamine
Both medications are cardiovascular agents frequently used in critical-care settings. Confusion can lead to inappropriate treatment and serious hemodynamic consequences.
B. Hydralazine vs Hydroxyzine
Hydralazine is an antihypertensive medication, while Hydroxyzine is an antihistamine. Name similarity can result in prescribing or dispensing errors.
C. Prednisone vs Prednisolone
These corticosteroids have similar names and indications, increasing the possibility of confusion.
D. Clonidine vs Klonopin
Clonidine is used primarily for hypertension and attention-related disorders, while Klonopin (clonazepam) is used for seizures and anxiety disorders.
E. Vinblastine vs Vincristine
These chemotherapy agents are among the most well-known LASA medication pairs. Confusion between them can result in severe patient harm.
F. Celebrex vs Celexa
Celebrex is used for pain and inflammation, while Celexa is an antidepressant. Their similar names have contributed to numerous medication errors.
G. Lamotrigine vs Labetalol
Differences in therapeutic use make accidental substitution potentially dangerous.
H. Zantac vs Xanax
Although indications differ greatly, sound similarity may contribute to prescribing or dispensing mistakes. Healthcare organizations have to maintain updated LASA medication lists and regularly educate staff regarding high-risk drug pairs.
10. Role of Pharmacists in Prevention
Pharmacists play a central role in promoting medication safety and preventing LASA-related errors. Their skills permit them to identify hazards throughout the medication-use process.
A. Prescription Verification
Pharmacists carefully review medication orders to ensure accuracy, appropriateness, and completeness.
This comprises verifying:
• Drug selection
• Dose
• Frequency
• Route of administration
• Potential interactions
B. Clinical Review
Pharmacists evaluate prescriptions within the context of the patient's clinical condition.
Probable errors can often be identified before medications reach patients.
C. Medication Storage Management
Pharmacists are responsible for organizing medication storage systems.
Efficient strategies include:
• Separating LASA medications
• Using warning labels
• Restricting access to high-risk drugs
• Applying standardized storage procedures
D. Staff Education
Pharmacists offer ongoing education regarding medication safety.
Training topics may include:
• LASA medication awareness
• Error prevention strategies
• New medication introductions
• Safe dispensing practices
E. Development of Safety Policies
Pharmacy departments help establish policies and procedures designed to reduce medication-related harm.
Examples include:
• Double-check requirements
• Barcode scanning procedures
• High-alert medication protocols
• Reporting systems
F. Error Reporting and Quality Improvement
Pharmacists play a major role in medication-safety programs by identifying, reporting, and analyzing errors and near misses.
Near-miss reporting is especially valuable because it allows organizations to learn from errors before patients are harmed.
G. Patient Counseling
Community pharmacists educate patients regarding:
• Medication names
• Indications
• Dosage instructions
• Expected appearance
When patients are aware, it offers another layer of safety. Pharmacists function as essential safeguards in the healthcare system and play a key role in reducing preventable medication errors.
11. WHO Recommendation
The World Health Organization (WHO) has identified medication safety as a global health priority and has developed several recommendations to reduce medication-related harm. Through its Global Patient Safety Challenge: Medication Without Harm, WHO encourages healthcare organizations to implement systematic approaches that improve medication safety and reduce preventable adverse events.
A. Standardized Medication Practices
Healthcare facilities should maintain standardized procedures for medication prescribing, dispensing, administration, and monitoring.
Standardization reduces variability and minimizes opportunities for error.
Examples include:
• Standard medication concentrations
• Standardized labeling systems
• Uniform storage practices
• Consistent documentation procedures
B. Risk Assessment
Healthcare organizations should routinely assess medication-use processes to recognize vulnerabilities.
Risk assessments support organizations in identifying:
• High-risk medications
• High-risk patient populations
• Unsafe workflows
• Potential LASA hazards
C. Staff Education and Training
Continuous education improves awareness of medication safety risks and supports best practices.
Training programs must include:
• LASA medication awareness
• Safe medication administration
• Error reporting procedures
• Human factors in patient safety
D. Reporting and Learning Systems
Healthcare workers should be encouraged to report medication errors and near misses without fear of punishment.
Effective reporting systems allow organizations to:
• Identify trends
• Analyze root causes
• Apply corrective actions
• Share lessons learned
E. Patient Safety Culture
WHO stresses the need to build a culture that focuses on safety instead of blame.
Organizations with strong safety cultures encourage:
• Frank communication
• Teamwork
• Continuous improvement
• Shared accountability
F. Technology Integration
Healthcare facilities should adopt technologies that reduce dependence on memory and manual processes.
Examples include:
• Electronic prescribing systems
• Barcode medication administration
• Clinical decision support systems
• Automated dispensing technologies
WHO points out that medication safety depends on teamwork among healthcare practitioners, regulators, manufacturers, policymakers, and patients.
12. Hospital-Level Prevention Strategies
Hospitals can implement numerous interventions to reduce the likelihood of LASA medication errors.
A. Physical Separation of LASA Medications
Look-alike medications should never be stored directly next to one another.
Physical separation reduces the risk of accidental selection.
Examples include:
• Separate shelves
• Separate drawers
• Dedicated storage areas
• High-alert medication cabinets
B. Use of Warning Labels
Warning labels draw attention to medications that are commonly confused.
Examples include:
• "High-Alert Medication"
• "Look-Alike Medication"
• "Verify Before Use"
These visual reminders prompt staff to check again before using the medication.
C. Independent Double Checks
Independent double checks require two qualified healthcare professionals to verify critical medication information before administration.
Verification should include:
• Patient identity
• Medication name
• Dose
• Route
• Timing
Double-check systems are especially important for high-risk medications.
D. Standardized Storage Systems
Medication storage should be organized consistently throughout the institution.
Benefits include:
• Reduced confusion
• Improved efficiency
• Easier staff training
• Strengthened safety
E. Restriction of High-Risk Medications
Certain medications should only be accessible to authorized staff.
Restricted access reduces opportunities for inappropriate selection or use.
F. Medication Safety Audits
Scheduled reviews help identify weaknesses before adverse events occur.
Audits may evaluate:
• Storage practices
• Labeling systems
• Compliance with policies
• Error trends
G. Medication Reconciliation
Medication reconciliation makes certain that medication information remains accurate during transitions of care. This process helps reduce medication errors and makes care safer for patients.
13. Community Pharmacy Prevention Strategies
Community pharmacies act as an essential checkpoint in the medication-use process because they are often the final healthcare setting before medications reach patients.
A. Organized Shelving Systems
Potentially confusing medications should not be stored adjacent to one another.
Pharmacies should develop storage systems that reduce LASA-related risks.
B. Barcode Verification
Barcode technology allows pharmacists and technicians to verify product identity during dispensing.
Benefits include:
• Better accuracy
• Reduced selection errors
• Enhanced workflow safety
C. Verification Procedures
Multiple checking steps should be incorporated into the dispensing process.
These may include:
• Technician verification
• Pharmacist verification
• Barcode confirmation
• Patient counseling
D. Patient Education
Patients should be encouraged to understand:
• Medication names
• Purpose of therapy
• Dosage instructions
• Expected appearance
When patients are informed, they can help protect themselves from medication mistakes.
E. Error Reporting
Community pharmacies should actively participate in medication-error reporting programs. Near misses are highly valuable because they provide opportunities for learning without patient harm.
F. Continuing Professional Development
Pharmacists and pharmacy technicians should engage in sustained education regarding:
• Emerging safety concerns
• New medications
• Updated guidelines
• Error-prevention strategies
Continuing to learn helps make pharmacy practice safer.
14. Technology and Barcode Verification
Technology has transformed medication safety by introducing automated safeguards capable of discovering and preventing many common medication errors.
A. Barcode Medication Administration (BCMA)
BCMA systems require healthcare professionals to scan both the patient and medication before administration.
The system verifies:
• Correct patient
• Correct medication
• Correct dose
• Correct route
• Correct time
Barcode systems make giving medications much safer by reducing errors.
B. Electronic Prescribing
Electronic prescribing eliminates many problems associated with handwritten prescriptions.
Benefits include:
• Improved legibility
• Reduced transcription errors
• Automated safety alerts
• Improved communication
C. Automated Dispensing Cabinets
Automated dispensing systems improve medication control and accountability.
Advantages include:
• Secure access
• Inventory tracking
• Reduced selection errors
• Improved process efficiency
D. Clinical Decision Support Systems (CDSS)
Clinical decision support tools offer real-time alerts regarding:
• Drug interactions
• Allergies
• Duplicate therapy
• Dose limits
These systems help healthcare professionals make safer choices.
E. Smart Infusion Pumps
Smart pumps contain built-in safety software that helps prevent infusion-related medication errors.
Functions include:
• Dose-limit checking
• Drug libraries
• Alert systems
F. Limitations of Technology
Although technology improves safety, it is not a complete solution.
Possible challenges include:
• Alert fatigue
• System failures
• User workarounds
• Training deficiencies
Technology should help, not replace, human decision and strong safety systems.
15. Tall-Man Lettering
Tall-Man lettering is a medication-safety strategy that uses selective capitalization to highlight differences between similar drug names.
This technique makes it easier to tell similar drug names apart and lowers the chance of confusion.
Examples include:
• DOBUTamine vs DOPamine
• hydrOXYzine vs hydrALAZINE
• vinBLAStine vs vinCRIStine
• predniSONE vs prednisoLONE
A. Purpose of Tall-Man Lettering
The main goal is to draw attention to unique portions of medication names.
This helps healthcare professionals tell medications apart more quickly and accurately.
B. Benefits
Research has demonstrated several benefits:
• Improved name recognition
• Reduced selection errors
• Increased awareness of LASA risks
• Better medication safety
C. Implementation Strategies
Healthcare organizations can incorporate Tall-Man lettering into:
• Medication labels
• Electronic prescribing systems
• Pharmacy software
• Educational materials
• Storage labels
D. Limitations
Tall-Man lettering should not be the only safety strategy used.
Maximum effectiveness occurs when combined with:
• Staff education
• Barcode verification
• Safe storage practices
• Independent double checks
When Tall-Man lettering is used as part of a bigger medication safety program, it can greatly reduce LASA-related mistakes.
16. Lessons Learned
The tragic death of infant Zoya offers important lessons for healthcare professionals, organizations, pharmaceutical companies, and decision-makers. Although this event involved just one patient, the factors that led to the error exist in many healthcare settings around the world.
A. Medication Errors Are Usually System Failures
One of the most important lessons from modern patient-safety science is that serious medication errors rarely result from a single individual's actions. Instead, they occur when multiple weaknesses in the healthcare system align.
Examples include:
• Similar medication packaging
• Poor storage practices
• Inadequate verification procedures
• Insufficient staff training
• Lack of technological protections
Organizations should focus on making their systems better instead of blaming individuals.
B. Visual Similarity Creates Significant Risk
Healthcare workers regularly depend on visual recognition when selecting medications. Similar vial sizes, colors, labels, and packaging designs can easily lead to confusion. Manufacturers should design packaging that clearly makes products different from each other.
C. Confirmation Methods Save Lives
Independent double-check systems can identify medication errors before they reach patients.
Verification should occur at multiple stages:
• Selection
• Preparation
• Dispensing
• Administration
Each step is a chance to catch a mistake before it reaches the patient.
D. Storage Practices Matter
How medications are physically arranged directly affects safety.
Healthcare organizations should:
• Separate LASA medications
• Use warning labels
• Standardize storage systems
• Restrict access to high-risk drugs
E. Technology Improves Safety
Barcode verification systems, electronic prescribing platforms, and clinical decision support tools supply valuable safeguards against medication errors. Even though technology cannot remove all risk, it does make human error much less likely.
F. Reporting Near Misses Is Essential
Near misses are events that could have resulted in harm but were detected before reaching the patient. Organizations that encourage reporting of near misses gain important insights into weaknesses in their systems. Learning from near misses helps prevent upcoming disasters.
G. Patient Safety Requires Teamwork
Medication safety is a shared responsibility.
Stakeholders include:
• Pharmacists
• Nurses
• Physicians
• Healthcare administrators
• Regulatory agencies
• Pharmaceutical manufacturers
• Patients and caregivers
Preventing errors successfully takes teamwork from everyone involved in the medication-use process.
17. Frequently Asked Questions (FAQ)
Q1. What are Look-Alike and Sound-Alike (LASA) medications?
LASA medications are drugs that may be confused because they have similar names, packaging, labeling, or appearances.
Examples include:
• Dopamine and Dobutamine
• Hydralazine and Hydroxyzine
• Celebrex and Celexa
These similarities increase the risk of medication-selection errors.
Q2. Why are LASA medications dangerous?
LASA medications can result in patients receiving the wrong medication.
Potential consequences include:
• Treatment failure
• Adverse drug reactions
• Hospitalization
• Permanent injury
• Death
The severity depends on the medications involved and the patient's condition.
Q3. Who is most vulnerable to LASA medication errors?
Although any patient can be affected, higher-risk populations include:
• Newborns
• Children
• Elderly patients
• Critically ill patients
• Patients receiving multiple medications
These groups often have limited physiological reserves and may be more susceptible to medication-related harm.
Q4. What is Tall-Man lettering?
Tall-Man lettering is a safety strategy that uses selective capitalization to emphasize differences between similar medication names.
Examples include:
• DOBUTamine vs DOPamine
• hydrOXYzine vs hydrALAZINE
The technique improves visual differentiation and reduces confusion.
Q5. Can technology prevent LASA errors?
Technology can significantly reduce risk but cannot eliminate errors.
Helpful technologies include:
• Barcode medication administration
• Electronic prescribing
• Clinical decision support systems
• Automated dispensing cabinets
Technology is most effective when combined with strong safety practices.
Q6. What role do pharmacists play in preventing medication errors?
Pharmacists function as critical safeguards within the medication-use process.
Their duties include:
• Reviewing prescriptions
• Verifying medication selection
• Managing storage systems
• Educating healthcare staff
• Counseling patients
• Participating in quality-improvement initiatives
Q7. Why is medication-error reporting important?
Reporting permits healthcare organizations to:
• Identify safety risks
• Analyze trends
• Improve systems
• Prevent future errors
Both actual errors and near misses afford valuable learning opportunities.
18. Conclusion
Look-Alike and Sound-Alike medications are still a major cause of preventable patient harm around the world. Even with better healthcare technology and safety programs, confusion over similar drug names, packaging, and labels still causes problems in hospitals, clinics, and community pharmacies. The case reported by WHO, where infant Zoya died after being given epinephrine instead of vitamin K, shows how devastating things can be when medication safety measures fail. This tragedy showed that medication errors are rarely caused by just one mistake. Usually, they happen because of a mix of system weaknesses, human factors, environmental issues, and not enough safeguards.
Healthcare organizations need to use a complete approach to medication safety. Good prevention strategies include keeping LASA medications apart, using barcode checks, Tall-Man lettering, standard workflows, independent double checks, persistent staff education, and continuous quality improvement. Pharmacists play a key role in reducing harm from medications. By reviewing prescriptions, checking medications, counseling patients, managing storage, and leading safety efforts, pharmacists help prevent avoidable mistakes.
In the end, improving medication safety takes teamwork through healthcare professionals, administrators, regulators, manufacturers, and patients. By studying past mistakes and using proven prevention strategies, medical systems can reduce LASA-related errors and keep patients safer.
Lessons from tragic cases like infant Zoya's should continue to guide efforts to make medication use safer everywhere. Every medication error prevented means better healthcare quality and, most importantly, saving lives.
19. References
1. World Health Organization (WHO). Medication Without Harm: WHO Global Patient Safety Challenge on Medication Safety.
2. World Health Organization. Patient Safety Curriculum Guide: Multi-professional Edition.
3. World Health Organization. Reporting and Learning Systems for Medication Errors.
4. Institute for Safe Medication Practices (ISMP). List of Confused Drug Names.
5. Institute for Safe Medication Practices. Guidelines for Safe Medication Practices.
6. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Medication Error Definitions and Prevention Strategies.
7. The Joint Commission. National Patient Safety Goals.
8. American Society of Health-System Pharmacists (ASHP). Guidelines on Preventing Medication Errors in Hospitals.
9. Agency for Healthcare Research and Quality (AHRQ). Patient Safety Network: Medication Errors.
10. International Medication Safety Network (IMSN). Recommendations for Reducing Look-Alike and Sound-Alike Medication Errors.
11. Institute of Medicine. Preventing Medication Errors.
12. World Alliance for Patient Safety. WHO Patient Safety Solutions.
13. International Pharmaceutical Federation (FIP). Patient Safety and Quality Criteria.
14. Institute for Healthcare Improvement (IHI). Medication Safety Improvement Resources.
15. ISMP Guidelines for Safe Electronic Communication of Medication Information.
Also visit
Post a Comment